Jae-Phil Choi

InstitutionSeoul Medical Center
AddressSouth Korea
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 8 Covid-19 publications, with a maximum of 2 publications in July 2020
    All Publications
    Bar chart showing 23 publications over 13 distinct years, with a maximum of 4 publications in 2020 and 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Cho Y, Sohn Y, Hyun J, Baek Y, Kim M, Kim J, Ahn J, Jeong S, Ku N, Yeom JS, Ahn M, Oh D, Choi J, Choi J, Kim S, Lee K, Song Y, Choi J. Effectiveness of Convalescent Plasma Therapy in Severe or Critically Ill COVID-19 Patients: A Retrospective Cohort Study. Yonsei Med J. 2021 Sep; 62(9):799-805. PMID: 34427065.
      Citations: 1     Fields:    Translation:Humans
    2. Kim YS, Aigerim A, Park U, Kim Y, Park H, Rhee JY, Choi JP, Park WB, Park SW, Kim Y, Lim DG, Choi JY, Jeon YK, Yang JS, Lee JY, Shin HS, Cho NH. Sustained Responses of Neutralizing Antibodies Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Recovered Patients and Their Therapeutic Applicability. Clin Infect Dis. 2021 08 02; 73(3):e550-e558. PMID: 32898238.
      Citations: 5     Fields:    Translation:HumansAnimalsCells
    3. Cheon S, Park U, Park H, Kim Y, Nguyen YTH, Aigerim A, Rhee JY, Choi JP, Park WB, Park SW, Kim Y, Lim DG, Yang JS, Lee JY, Kim YS, Cho NH. Longevity of seropositivity and neutralizing antibodies in recovered MERS patients: a 5-year follow-up study. Clin Microbiol Infect. 2022 Feb; 28(2):292-296. PMID: 34139334.
      Citations:    Fields:    
    4. Hahm CR, Lee YK, Oh DH, Ahn MY, Choi JP, Kang NR, Oh J, Choi H, Kim S. Factors Associated with Worsening Oxygenation in Patients with Non-severe COVID-19 Pneumonia. Tuberc Respir Dis (Seoul). 2021 Apr; 84(2):115-124. PMID: 33401345.
      Citations: 1     
    5. Rha MS, Jeong HW, Ko JH, Choi SJ, Seo IH, Lee JS, Sa M, Kim AR, Joo EJ, Ahn JY, Kim JH, Song KH, Kim ES, Oh DH, Ahn MY, Choi HK, Jeon JH, Choi JP, Kim HB, Kim YK, Park SH, Choi WS, Choi JY, Peck KR, Shin EC. PD-1-Expressing SARS-CoV-2-Specific CD8+ T Cells Are Not Exhausted, but Functional in Patients with COVID-19. Immunity. 2021 01 12; 54(1):44-52.e3. PMID: 33338412.
      Citations: 49     Fields:    Translation:HumansCells
    6. Lee C, Ahn MY, Byeon K, Choi JP, Hahm C, Kim H, Kim S, Kim TH, Oh J, Oh DH. Clinical Experience with Use of Remdesivir in the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: a Case Series. Infect Chemother. 2020 Sep; 52(3):369-380. PMID: 32757500.
      Citations: 4     
    7. Ahn MY, Oh DH, Kim S, Choi JP, Lee JH, Lee YK, Hong KH. Four cases of coronavirus disease 2019 in the early stage of pandemic of South Korea: a single public hospital experience. Korean J Intern Med. 2020 07; 35(4):788-792. PMID: 32668515.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    8. Kim ES, Chin BS, Kang CK, Kim NJ, Kang YM, Choi JP, Oh DH, Kim JH, Koh B, Kim SE, Yun NR, Lee JH, Kim JY, Kim Y, Bang JH, Song KH, Kim HB, Chung KH, Oh MD. Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19. J Korean Med Sci. 2020 Apr 06; 35(13):e142. PMID: 32242348.
      Citations: 118     Fields:    Translation:HumansCellsPHPublic Health
    9. Kim YS, Aigerim A, Park U, Kim Y, Rhee JY, Choi JP, Park WB, Park SW, Kim Y, Lim DG, Inn KS, Hwang ES, Choi MS, Shin HS, Cho NH. Sequential Emergence and Wide Spread of Neutralization Escape Middle East Respiratory Syndrome Coronavirus Mutants, South Korea, 2015. Emerg Infect Dis. 2019 06; 25(6):1161-1168. PMID: 30900977.
      Citations: 11     Fields:    Translation:HumansCellsPHPublic Health
    10. Choi JY, Oh JO, Ahn JY, Choi H, Kim JH, Seong H, Jeong SJ, Ku NS, Yeom JS, Choi JP. Absence of neutralizing activity in serum 1 year after successful treatment with antivirals and recovery from MERS in South Korea. Clin Exp Vaccine Res. 2019 Jan; 8(1):86-88. PMID: 30775355.
      Citations: 3     
    11. Park WB, Jun KI, Kim G, Choi JP, Rhee JY, Cheon S, Lee CH, Park JS, Kim Y, Joh JS, Chin BS, Choe PG, Bang JH, Park SW, Kim NJ, Lim DG, Kim YS, Oh MD, Shin HS. Correlation between Pneumonia Severity and Pulmonary Complications in Middle East Respiratory Syndrome. J Korean Med Sci. 2018 Jun 11; 33(24):e169. PMID: 29892209.
      Citations: 37     Fields:    Translation:Humans
    12. Hong KH, Choi JP, Hong SH, Lee J, Kwon JS, Kim SM, Park SY, Rhee JY, Kim BN, Choi HJ, Shin EC, Pai H, Park SH, Kim SH. Predictors of mortality in Middle East respiratory syndrome (MERS). Thorax. 2018 03; 73(3):286-289. PMID: 28724637.
      Citations: 78     Fields:    Translation:HumansCells
    13. Kim JE, Heo JH, Kim HO, Song SH, Park SS, Park TH, Ahn JY, Kim MK, Choi JP. Neurological Complications during Treatment of Middle East Respiratory Syndrome. J Clin Neurol. 2017 Jul; 13(3):227-233. PMID: 28748673.
      Citations: 200     
    14. Choi WS, Kang CI, Kim Y, Choi JP, Joh JS, Shin HS, Kim G, Peck KR, Chung DR, Kim HO, Song SH, Kim YR, Sohn KM, Jung Y, Bang JH, Kim NJ, Lee KS, Jeong HW, Rhee JY, Kim ES, Woo H, Oh WS, Huh K, Lee YH, Song JY, Lee J, Lee CS, Kim BN, Choi YH, Jeong SJ, Lee JS, Yoon JH, Wi YM, Joung MK, Park SY, Lee SH, Jung SI, Kim SW, Lee JH, Lee H, Ki HK, Kim YS. Clinical Presentation and Outcomes of Middle East Respiratory Syndrome in the Republic of Korea. Infect Chemother. 2016 Jun; 48(2):118-26. PMID: 27433382.
      Citations: 64     
    15. Kim SH, Chang SY, Sung M, Park JH, Bin Kim H, Lee H, Choi JP, Choi WS, Min JY. Extensive Viable Middle East Respiratory Syndrome (MERS) Coronavirus Contamination in Air and Surrounding Environment in MERS Isolation Wards. Clin Infect Dis. 2016 08 01; 63(3):363-9. PMID: 27090992.
      Citations: 81     Fields:    Translation:HumansCellsPHPublic Health
    16. Chong YP, Song JY, Seo YB, Choi JP, Shin HS. Antiviral Treatment Guidelines for Middle East Respiratory Syndrome. Infect Chemother. 2015 Sep; 47(3):212-22. PMID: 26483999.
      Citations: 39